☰

Marcin P. Iwanicki, Ph.D. - Publications

Affiliations: 
University of Virginia, Charlottesville, VA 
Area:
Signal transduction
Tree Info Grants Similar researchers PubMed Report error

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Reavis HD, Gysler SM, McKenney GB, Knarr M, Lusk HJ, Rawat P, Rendulich HS, Mitchell MA, Berger DS, Moon JS, Ryu S, Mainigi M, Iwanicki MP, Hoon DS, Sanchez LM, et al. Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells. Jci Insight. PMID 38271085 DOI: 10.1172/jci.insight.170961  0.309
2023 Centeno D, Farsinejad S, Kochetkova E, Volpari T, Klupczynska-Gabryszak A, Kung D, Polotaye T, Hyde E, Pavlovic T, Alshehri S, Sullivan W, Plewa S, Monsma FJ, Matysiak J, Zaborowski M, ... ... Iwanicki M, et al. The Dietary Supplement Taurine Suppresses Ovarian Cancer Growth. Biorxiv : the Preprint Server For Biology. PMID 36909636 DOI: 10.1101/2023.02.24.529893  0.343
2022 Doberstein K, Spivak R, Reavis HD, Hooda J, Feng Y, Kroeger PT, Stuckelberger S, Mills GB, Devins KM, Schwartz LE, Iwanicki MP, Fogel M, Altevogt P, Drapkin R. L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary. Communications Biology. 5: 1362. PMID 36509990 DOI: 10.1038/s42003-022-04314-8  0.36
2022 Alshehri S, Pavlovič T, Farsinejad S, Behboodi P, Quan L, Centeno D, Kung D, Rezler M, Lee W, Jasiński P, Dziabaszewska E, Nowak-Markwitz E, Kalyon D, Zaborowski MP, Iwanicki M. Extracellular Matrix Modulates Outgrowth Dynamics in Ovarian Cancer. Advanced Biology. e2200197. PMID 36084257 DOI: 10.1002/adbi.202200197  0.405
2021 Tangri A, Lighty K, Loganathan J, Mesmar F, Podicheti R, Zhang C, Iwanicki M, Drapkin R, Nakshatri H, Mitra S. Deubiquitinase UCHL1 Maintains Protein Homeostasis through the PSMA7-APEH-Proteasome Axis in High-Grade Serous Ovarian Carcinoma. Molecular Cancer Research : McR. PMID 33753553 DOI: 10.1158/1541-7786.MCR-20-0883  0.327
2020 Izar B, Tirosh I, Stover EH, Wakiro I, Cuoco MS, Alter I, Rodman C, Leeson R, Su MJ, Shah P, Iwanicki M, Walker SR, Kanodia A, Melms JC, Mei S, et al. A single-cell landscape of high-grade serous ovarian cancer. Nature Medicine. PMID 32572264 DOI: 10.1038/S41591-020-0926-0  0.467
2020 Kozlova N, Grossman JE, Iwanicki MP, Muranen T. The Interplay of the Extracellular Matrix and Stromal Cells as a Drug Target in Stroma-Rich Cancers. Trends in Pharmacological Sciences. 41: 183-198. PMID 32014341 DOI: 10.1016/J.Tips.2020.01.001  0.407
2020 Alshehri S, Farsinejad S, Kung D, Santi E, Zhai Y, Cattabiani T, Wang H, Cho K, Iwanicki M. Abstract B11: Collective extrusion initiates dissemination in organotypic model of high-grade serous carcinoma Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Ovca19-B11  0.47
2020 Lighty K, Shin Y, Mesmer F, Nakshatri H, Iwanicki M, Mitra S. Abstract A54: Targeting new links in the proteostasis network as novel therapies in high-grade serous ovarian cancer Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Ovca19-A54  0.448
2019 Farsinejad S, Cattabiani T, Muranen T, Iwanicki M. Ovarian Cancer Dissemination-A Cell Biologist's Perspective. Cancers. 11. PMID 31817625 DOI: 10.3390/Cancers11121957  0.418
2019 Zaborowski MP, Lee K, Na YJ, Sammarco A, Zhang X, Iwanicki M, Cheah PS, Lin HY, Zinter M, Chou CY, Fulci G, Tannous BA, Lai CP, Birrer MJ, Weissleder R, et al. Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles. Cell Reports. 27: 255-268.e6. PMID 30943406 DOI: 10.1016/J.Celrep.2019.03.003  0.386
2018 Doberstein K, Iwanicki M, Fogel M, Altevogt P, Drapkin R. Abstract B42: The cell adhesion molecule, L1CAM, is important for the dissemination and metastasis of fallopian tube precursor lesions Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Ovca17-B42  0.453
2018 Hendrick NM, Iwanicki MP, Li CM, Bui DA, Selfors LM, Brugge JS. Abstract 3155: Loss of YAP1 dysregulates RhoA signaling and promotes cell invasion Cancer Research. 78: 3155-3155. DOI: 10.1158/1538-7445.Am2018-3155  0.519
2017 Eriksson M, Ambroise G, Ouchida AT, Queiroz AL, Smith D, Gimenez-Cassina A, Iwanicki MP, Muller PA, Norberg E, Vakifahmetoglu-Norberg H. The effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism. Molecular and Cellular Biology. PMID 28993478 DOI: 10.1128/Mcb.00328-17  0.387
2017 Medrano M, Communal L, Brown KR, Iwanicki M, Normand J, Paterson J, Sircoulomb F, Krzyzanowski P, Novak M, Doodnauth SA, Saiz FS, Cullis J, Al-Awar R, Neel BG, McPherson J, et al. Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer. Cell Reports. 18: 2343-2358. PMID 28273451 DOI: 10.1016/J.Celrep.2017.02.028  0.399
2017 Muranen T, Iwanicki MP, Curry NL, Hwang J, DuBois CD, Coloff JL, Hitchcock DS, Clish CB, Brugge JS, Kalaany NY. Starved epithelial cells uptake extracellular matrix for survival. Nature Communications. 8: 13989. PMID 28071763 DOI: 10.1038/Ncomms13989  0.478
2016 Sheets JN, Iwanicki M, Liu JF, Howitt BE, Hirsch MS, Gubbels JA, Drapkin R, Egland KA. SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance. Oncogenesis. 5: e264. PMID 27775699 DOI: 10.1038/oncsis.2016.64  0.424
2016 Iwanicki MP, Chen HY, Iavarone C, Zervantonakis IK, Muranen T, Novak M, Ince TA, Drapkin R, Brugge JS. Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. Jci Insight. 1. PMID 27482544 DOI: 10.1172/Jci.Insight.86829  0.472
2016 Iwanicki MP, Chen H, Zervantonakis I, Novak M, Muranen T, Ince TA, Drapkin R, Brugge JS. Abstract PR12: Mutant p53 drives early events in fallopian tube tumorigenesis through mesenchyme-associated autocrine production of matrix that supports survival and mesothelial intercalation. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-Pr12  0.506
2015 Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ, Bast RC, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, Brenton JD, Chiappinelli KB, Martins FC, Coukos G, Drapkin R, ... ... Iwanicki M, et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nature Reviews. Cancer. 15: 668-79. PMID 26493647 DOI: 10.1038/Nrc4019  0.335
2015 Sheets JN, Iwanicki M, Liu J, Drapkin R, Egland KA. Abstract POSTER-BIOL-1345: SUSD2 inhibits spheroids from breaching the mesothelium: a mechanism for increased longevity of patients with SUSD2-expressing high-grade ovarian serous carcinoma Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Biol-1345  0.488
2014 Davidowitz RA, Selfors LM, Iwanicki MP, Elias KM, Karst A, Piao H, Ince TA, Drage MG, Dering J, Konecny GE, Matulonis U, Mills GB, Slamon DJ, Drapkin R, Brugge JS. Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. The Journal of Clinical Investigation. 124: 2611-25. PMID 24762435 DOI: 10.1172/Jci69815  0.502
2014 Maninová M, Iwanicki MP, Vomastek T. Emerging role for nuclear rotation and orientation in cell migration. Cell Adhesion & Migration. 8: 42-8. PMID 24589621 DOI: 10.4161/Cam.27761  0.411
2013 Merritt MA, Bentink S, Schwede M, Iwanicki MP, Quackenbush J, Woo T, Agoston ES, Reinhardt F, Crum CP, Berkowitz RS, Mok SC, Witt AE, Jones MA, Wang B, Ince TA. Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomes. Plos One. 8: e80314. PMID 24303006 DOI: 10.1371/Journal.Pone.0080314  0.438
2013 Vakifahmetoglu-Norberg H, Kim M, Xia HG, Iwanicki MP, Ofengeim D, Coloff JL, Pan L, Ince TA, Kroemer G, Brugge JS, Yuan J. Chaperone-mediated autophagy degrades mutant p53. Genes & Development. 27: 1718-30. PMID 23913924 DOI: 10.1101/Gad.220897.113  0.433
2013 Maninová M, Klímová Z, Parsons JT, Weber MJ, Iwanicki MP, Vomastek T. The reorientation of cell nucleus promotes the establishment of front-rear polarity in migrating fibroblasts. Journal of Molecular Biology. 425: 2039-55. PMID 23524135 DOI: 10.1016/J.Jmb.2013.02.034  0.53
2013 Iwanicki MP, Novak M, Zervantonakis IK, Ince TA, Drapkin R, Brugge JS. Abstract A7: Targeting mutant p53 and cell-cell adhesion in ovarian cancer Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A7  0.457
2012 Davidowitz RA, Iwanicki MP, Brugge JS. In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis. Journal of Visualized Experiments : Jove. PMID 22371143 DOI: 10.3791/3888  0.512
2012 Muranen T, Selfors LM, Worster DT, Iwanicki MP, Song L, Morales FC, Gao S, Mills GB, Brugge JS. Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. Cancer Cell. 21: 227-39. PMID 22340595 DOI: 10.1016/J.Ccr.2011.12.024  0.458
2012 Muranen TE, Selfors L, Worster D, Iwanicki M, Song L, Morlaes F, Mills GB, Brugge JS. Abstract 4836: Inhibition of PI3K/mTOR leads to adaptive resistance in extracellular matrix attached cancer cells Cancer Research. 72: 4836-4836. DOI: 10.1158/1538-7445.Am2012-4836  0.457
2011 Iwanicki MP, Davidowitz RA, Ng MR, Besser A, Muranen T, Merritt M, Danuser G, Ince TA, Ince T, Brugge JS. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discovery. 1: 144-57. PMID 22303516 DOI: 10.1158/2159-8274.Cd-11-0010  0.454
2011 Davidowitz R, Iwanicki M, Selfors L, Konecny G, Dering J, Slamon D, Brugge J. Abstract 4751: Identification of mechanism involved in mesothelial clearance by ovarian tumor spheroids Cancer Research. 71: 4751-4751. DOI: 10.1158/1538-7445.Am2011-4751  0.509
2011 Muranen TE, Morales F, Selfors L, Worster D, Albeck J, Gao S, Iwanicki M, Mills G, Brugge JS. Abstract 1540: Targeting PI3K/mTOR inhibitor induced survival programs abrogates resistance to cell death in ECM-attached cancer cells Cancer Research. 71: 1540-1540. DOI: 10.1158/1538-7445.Am2011-1540  0.483
2011 Brugge J, Muranen T, Zoeller J, Worster D, Iwanicki M, Selfors L, Mills G. DL1-1: Adaptive Resistance to Targeted Therapies. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Dl1-1  0.349
2010 Thomas J. PJ, Slack-Davis JK, Tilghman RW, Iwanicki M, Martin KH. Integrin signaling. cell migration, proliferation, and survival Handbook of Cell Signaling, 2/E. 2: 491-499. DOI: 10.1016/B978-0-12-374145-5.00066-8  0.319
2009 Muller PA, Caswell PT, Doyle B, Iwanicki MP, Tan EH, Karim S, Lukashchuk N, Gillespie DA, Ludwig RL, Gosselin P, Cromer A, Brugge JS, Sansom OJ, Norman JC, Vousden KH. Mutant p53 drives invasion by promoting integrin recycling. Cell. 139: 1327-41. PMID 20064378 DOI: 10.1016/J.Cell.2009.11.026  0.413
2009 Iwanicki MP, Brugge JS. Transcriptional regulation of metastatic [Id]entity by KLF17. Genome Biology. 10: 244. PMID 19951400 DOI: 10.1186/Gb-2009-10-11-244  0.309
2008 Vomastek T, Iwanicki MP, Burack WR, Tiwari D, Kumar D, Parsons JT, Weber MJ, Nandicoori VK. Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction. Molecular and Cellular Biology. 28: 6954-66. PMID 18794356 DOI: 10.1128/Mcb.00925-08  0.47
2008 Iwanicki MP, Vomastek T, Tilghman RW, Martin KH, Banerjee J, Wedegaertner PB, Parsons JT. FAK, PDZ-RhoGEF and ROCKII cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts. Journal of Cell Science. 121: 895-905. PMID 18303050 DOI: 10.1242/Jcs.020941  0.53
2007 Vomastek T, Iwanicki MP, Schaeffer HJ, Tarcsafalvi A, Parsons JT, Weber MJ. RACK1 targets the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to link integrin engagement with focal adhesion disassembly and cell motility. Molecular and Cellular Biology. 27: 8296-305. PMID 17908799 DOI: 10.1128/Mcb.00598-07  0.525
2007 Slack-Davis JK, Martin KH, Tilghman RW, Iwanicki M, Ung EJ, Autry C, Luzzio MJ, Cooper B, Kath JC, Roberts WG, Parsons JT. Cellular characterization of a novel focal adhesion kinase inhibitor Journal of Biological Chemistry. 282: 14845-14852. PMID 17395594 DOI: 10.1074/Jbc.M606695200  0.571
2005 Tilghman RW, Slack-Davis JK, Sergina N, Martin KH, Iwanicki M, Hershey ED, Beggs HE, Reichardt LF, Parsons JT. Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells. Journal of Cell Science. 118: 2613-23. PMID 15914540 DOI: 10.1242/Jcs.02380  0.59
Show low-probability matches.